XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash and Cash Equivalents $ 5,565,074 $ 7,312,095
Restricted Cash 122,951 129,527
Accounts Receivable, Net 439,430 1,222,690
Inventory, Net 487,747 526,470
Other Current Assets 324,291 371,990
Total Current Assets 6,939,493 9,562,772
PROPERTY AND EQUIPMENT, NET 651,931 32,911
OTHER ASSETS    
Other Assets 427,049 267,387
Total Other Assets 427,049 267,387
Total Assets 8,018,473 9,863,070
CURRENT LIABILITIES    
Accounts and Other Payables 1,161,569 1,638,727
Short Term Debt 176,885 398,409
Current Portion of Long-Term Debt 65,408
Total Current Liabilities 1,338,454 2,102,544
LONG-TERM DEBT 190,776
STOCKHOLDERS’ EQUITY    
Preferred Stock, value  
Common Stock, $0.00001 par value; 100,000,000 shares authorized; 16,069,891 and 15,066,739 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 161 150
Additional Paid-In Capital 53,881,334 52,496,914
Joint Venture Non-Controlled Portion (83,489)
Accumulated Comprehensive Loss (274,862) (220,643)
Accumulated Deficit (46,843,124) (44,706,671)
Total Stockholders’ Equity (Deficit) 6,680,020 7,569,750
Total Liabilities and Stockholders’ Equity 8,018,473 9,863,070
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred Stock, value  
Related Party [Member]    
CURRENT LIABILITIES    
Due to Related Parties